Home › Stocks › PCSA › Changes

Who bought & sold PCSA (Q3 2026)

Funds holding (Q3 2026)12
New positions4
Added2
Reduced2
Exited5

As of Q3 2026, 12 institutional funds reported holding PCSA (PROCESSA PHARMACEUTICALS INC): 4 opened new positions, 2 added, 2 trimmed and 5 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (4)

Fund Shares Value Weight
ADAGE CAPITAL PARTNERS GP, L.L.C. New 3.28M $5.37M 0.0
JPMorgan Chase & Co New 18 $32 —
Fidelity Management & Research (FMR) New 6 $10 —
BARCLAYS PLC New 3 $5 —

Added to positions (2)

Fund Shares Value Weight Change
Geode Capital Management 31.25K $51.25K — +9.16K sh (+41.5%)
JANE STREET GROUP, LLC 13.57K $22.26K — +307 sh (+2.3%)

Reduced positions (2)

Fund Shares Value Weight Change
Tower Research Capital LLC (TRC) 419 $687 — -2.08K sh (-83.2%)
UBS Group AG 6.77K $11.11K — -1.02K sh (-13.1%)

Exited positions (5)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
Stonepine Capital Management, LLC Exited 55.00K $105.60K 0.1
GEODE CAPITAL MANAGEMENT, LLC Exited 22.09K $42.41K —
Citadel Advisors Exited 21.31K $40.91K —
StoneX Group Inc. Exited 11.44K $29.62K 0.0
XTX Topco Ltd Exited 13.29K $25.52K —